Abstract CT082: Capmatinib in METex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM)
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Edward B. Garon, Rebecca S. Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Harry J. Groen, Daniel SW Tan, Toyoaki Hida, Maja J. de Jonge, Sergey V. Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf
Institutions: University of California, Los Angeles, Massachusetts General Hospital, National Hospital Organization Kyushu Cancer Center, National Cancer Center, Hospital Clínic de Barcelona, University Medical Center Groningen, University of Groningen, National Cancer Centre Singapore, Aichi Cancer Center, Erasmus MC, Erasmus MC Cancer Institute, First Pavlov State Medical University of St. Petersburg, The Netherlands Cancer Institute, Hôpital Lyon Sud, Universitair Ziekenhuis Leuven, KU Leuven, Novartis (France), Novartis (United States), Novartis (Switzerland), University Hospital Cologne
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3082532324